FAQ About Bernhard Hering

• What is Bernhard Hering's address?

  Bernhard Hering is located at
  Minneapolis, Minnesota, United States

• What is Bernhard Hering's job title?

  Bernhard Hering is a
  Bernhard J. Hering, M.D, is Professor and Vice Chair of Translational Medicine in the Department of Surgery, Executive Director of the Schulze Diabetes Institute and Director of Islet Transplantation at the University of Minnesota, where he holds the Jeffrey Dobbs and David Sutherland, MD, PhD Chair in Diabetes Research and the McKnight Presidential Chair in Transplantation Science. Dr. Hering is internationally renowned for his expertise in islet cell transplantation for the treatment of diabetes. His collaborative research on antigen-specific immune tolerance of transplants has been considered an important breakthrough in transplantation medicine, possibly eliminating the need for immunosuppression to prevent rejection of transplanted cells and organs. Dr. Hering is also widely recognized as a leader in investigating the use of alternative sources of islet cells through xenotransplantation. His research group was the first to demonstrate long-term diabetes reversal after adult porcine islet xenotransplants in nonhuman primates, an accomplishment that has reinvigorated the field of xenotransplantation. Dr. Hering co-founded Spring Point Project, an organization established to generate designated pathogen-free, ‘medical-grade’ source porcine donors for planned clinical translation of islet xenotransplantation. A sought-after speaker, he has given more than 300 invited lectures including key note lectures at national and international conferences. He is the author or co-author of over 350 articles, including publications in Diabetes Care, JAMA, Nature, Nature Communications, Nature Medicine, and the New England Journal of Medicine. Dr. Hering has been a member of steering committees of major research initiatives of the National Institutes of Health (NIH), including the Clinical Islet Transplantation Consortium, Immune Tolerance Network, Nonhuman Primate Transplantation Tolerance Collaborative Study Group, and Immunobiology of Xenotransplantation Collaborative Study Group and has been the Medical Director of the NIH Collaborative Islet Transplant Registry since its inception. Dr. Hering has served as President of the Cell Transplant Society, International Xenotransplantation Association, and International Pancreas and Islet Transplantation Association. In recognition for his outstanding contributions to islet transplantation, Dr. Hering was named by U.S. News & World Report and Castle Connolly Medical Ltd. one of America’s Top Doctors, a distinction reserved for the top 1% of physicians across the U.S. for their specialty. University Of Minnesota

• What industry does Bernhard Hering currently work in?

  Bernhard Hering currently works in the
  University Of Minnesota

• What is Bernhard Hering's area of expertise?

  Bernhard Hering specializes in
  Bernhard J. Hering, M.D, is Professor and Vice Chair of Translational Medicine in the Department of Surgery, Executive Director of the Schulze Diabetes Institute and Director of Islet Transplantation at the University of Minnesota, where he holds the Jeffrey Dobbs and David Sutherland, MD, PhD Chair in Diabetes Research and the McKnight Presidential Chair in Transplantation Science. Dr. Hering is internationally renowned for his expertise in islet cell transplantation for the treatment of diabetes. His collaborative research on antigen-specific immune tolerance of transplants has been considered an important breakthrough in transplantation medicine, possibly eliminating the need for immunosuppression to prevent rejection of transplanted cells and organs. Dr. Hering is also widely recognized as a leader in investigating the use of alternative sources of islet cells through xenotransplantation. His research group was the first to demonstrate long-term diabetes reversal after adult porcine islet xenotransplants in nonhuman primates, an accomplishment that has reinvigorated the field of xenotransplantation. Dr. Hering co-founded Spring Point Project, an organization established to generate designated pathogen-free, ‘medical-grade’ source porcine donors for planned clinical translation of islet xenotransplantation. A sought-after speaker, he has given more than 300 invited lectures including key note lectures at national and international conferences. He is the author or co-author of over 350 articles, including publications in Diabetes Care, JAMA, Nature, Nature Communications, Nature Medicine, and the New England Journal of Medicine. Dr. Hering has been a member of steering committees of major research initiatives of the National Institutes of Health (NIH), including the Clinical Islet Transplantation Consortium, Immune Tolerance Network, Nonhuman Primate Transplantation Tolerance Collaborative Study Group, and Immunobiology of Xenotransplantation Collaborative Study Group and has been the Medical Director of the NIH Collaborative Islet Transplant Registry since its inception. Dr. Hering has served as President of the Cell Transplant Society, International Xenotransplantation Association, and International Pancreas and Islet Transplantation Association. In recognition for his outstanding contributions to islet transplantation, Dr. Hering was named by U.S. News & World Report and Castle Connolly Medical Ltd. one of America’s Top Doctors, a distinction reserved for the top 1% of physicians across the U.S. for their specialty.

• Which languages does Bernhard Hering speak? 

  Bernhard Hering speaks the following languages:
  No languages available.

• Which industries has Bernhard Hering previously worked in?   

  Bernhard Hering has prior experience in the following industries:
  International Pancreas And Islet Transplant Association , Nih Type 1 Diabetes Trialnet , International Xenotransplantation Association , Spring Point Project , Nih Type 1 Diabetes Trialnet , Cell Transplant Society , Nih Immune Tolerance Network

• What is Bernhard Hering’s work experience?  

  Bernhard Hering has the following professional experience:
  University Of Minnesota , International Pancreas And Islet Transplant Association , Nih Clinical Islet Transplant Consortium , Nih Nonhuman Primate Transplantation Collaborative Study , Nih Type 1 Diabetes Trialnet , International Xenotransplantation Association , University Of Minnesota , Spring Point Project , Nih Type 1 Diabetes Trialnet , Cell Transplant Society , Nih Collaborative Islet Transplant Registry , Nih Immune Tolerance Network , University Of Minnesota .

• How can I find Bernhard Hering on LinkedIn?  

  You can view Bernhard Hering’s
  LinkedIn profile at LinkedIn URL.

• What are Bernhard Hering’s work email addresses?  

  Bernhard Hering’s work email addresses are
  [email protected].

• What company does Bernhard Hering work for?  

  Bernhard Hering works at
  University Of Minnesota